You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 769 Interim clinical and translational data from NTC-001, a phase I study to evaluate the non-engineered neoantigen-specific T cell product BNT221 in patients with advanced or metastatic melanoma

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
769 Interim clinical and translational data from NTC-001, a phase I study to evaluate the non-engineered neoantigen-specific T cell product BNT221 in patients with advanced or metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023305021
Dec 20233608
Jan 202465010
Feb 20244802
Mar 20243207
Apr 20242801
May 20242602
Jun 20245006
Jul 202412203
Aug 20243403
Sep 202446022
Oct 202462010
Nov 20245008
Dec 20247804
Jan 202562012
Feb 20252902
Mar 2025003
Apr 2025005
May 2025103
Jun 2025004
Total10740136